Title for MeetingAbstracts
Alphabetical listing of titles
-
Double (3tc + d4t) vs triple (3tc + d4t + saquinavir) therapy in HIV-1 experienced patients (ZDV + ddC/ddI) with a low baseline HIV-1 viral load (median 4089 copies/ml).
-
Double (3TC + d4T) vs triple (3TC + d4T + Saquinavir) therapy in HIV-1 experienced patients (ZDV + ddC/ddI) with a low baseline HIV-1 viral load. (median 4,089 copies/ml).
-
Double blind placebo controlled study of exercise and oxandrolone on lean mass, fat distribution, blood lipids, bone density and training markers in HIV infected men and women on HAART.
-
Double blind placebo controlled trial of oral dehydroepiandrosterone (DHEA) in advanced HIV-infected patients.
-
Double blind, placebo (PLC) controlled 6 month study to assess the promotion of weight gain and the effect on quality of life of megestrol acetate (MA) in HIV seropositive patients with weight loss.
-
Double blind, placebo controlled trial of high dose acyclovir for the prevention of cytomegalovirus (CMV) disease in late stage HIV disease. European-Australian Acyclovir Study Group.
-
Double gene knockouts in the LYS2 locus of the pathogenic yeast Candida albicans.
-
Double HIV1 and HIV2 seropositivity in Guinea.
-
Double impact: integrating prevention, community sensitization &mobilization for sustainable community based care and support by service delivery for people living with HIV/AIDS &affected families in rural Andhra Pradesh, India.
-
Double infection of lymphocytes with HBV and HIV is a rare event.
-
Double jeapody: findings from Project HIGH on gay men who inject drugs and prevention education in Melbourne, Australia.
-
Double Jeopardy: The Impact of Race/Ethnicity and Health Insurance.
-
Double lives: current problems faced by HIV-infected physicians.
-
Double nucleoside analog therapy in patients with acute/primary HIV infection.
-
Double or nothing? A baseline study of the impact of availability of cardiac services on racial differences in cardiac service use and mortality.
-
Double or triple therapy anti-HIV: a Brazilian dillema.
-
Double reactive sera for HIV1 and HIV2 antibodies and HIV variant strain from West Africa.
-
Double Stage Activity in Aminoglycoside Antibiotics.
-
Double staining CD4+CD8+ T cells in blood samples from HIV+ patients in T lymphocyte subset immunophenotyping at Instituto Adolfo Lutz (IAL), Sao Paulo-SP, Brazil.
-
Double stigma and discrimination faced within own community by PLWHA MSM.
-
Double stigma: the experience of gay men infected with HIV.
-
Double, boosted salvage therapy with lopinavir(LOP)/ritonavir(RIT) and saquinavir-sgc(SQR) in HIV-1 infected patients having failed 3 antiretroviral classes.
-
Double-blind comparison of the safety profile of (ddI) and (ZDV) among HIV+ individuals with CD4 counts 200 to 500 cells/mm3 treated with ZDV for > or = 6 months. The Bristol-Myers Squibb (USA) AI454-033 Study Group.
-
Double-blind dose-response study of zidovudine in AIDS and serious HIV infection (AIDSdose).
-
Double-blind dose-response study of zidovudine in serious HIV infection and AIDS.
-
Double-blind placebo controlled study of recombinant human erythropoietin in AIDS patients with anemia caused by HIV infection and zidovudine.
-
Double-blind placebo controlled trial of the efficacy of lithium in treating neutropenia in HIV infected patients.
-
Double-blind placebo(P)-controlled cross-over study fails to show benefit of mexiletine (MX) in painful neuropathy.
-
Double-blind randomized comparison of oral trimethoprim- sulfamethoxazole (TS), dapsone-trimethoprim (DT), and clindamycin-primaquine (CP) for treatment of mild-to-moderate pneumocystis carinii pneumonia (PCP) in AIDS patients.
-
Double-blind randomized controlled trial of the role of corticosteroids (CS) in Penumocystis carinii pneumonia (PCP) in AIDS.